What is PAHC revenue?

Phibro Animal Health Corporation (PAHC) reported $1.54B of revenue for the twelve months ended Sep 30, 2026. That is up 10.1% from the year before. Revenue for fiscal 2026 was $1.52B.

Yes. Phibro Animal Health Corporation earned $102.71M in net income for the twelve months ended Sep 30, 2026, a net margin of 6.7%.

How much cash and debt does PAHC have?

Phibro Animal Health Corporation reported $75.55M in cash and cash equivalents and $610.88M of debt on its most recent balance sheet in SEC filings.

How fast is PAHC revenue growing?

Phibro Animal Health Corporation's revenue changed +17.1% in fiscal 2026, to $1.52B. Its compound annual growth rate was +12.7% over 5 years and +7.3% over 10 years.

What is PAHC gross margin?

Phibro Animal Health Corporation's gross profit was $521.27M on $1.54B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 33.8%.

What is PAHC free cash flow?

Phibro Animal Health Corporation generated $21.67M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $85.73M less capital expenditures.

What is PAHC earnings per share?

Diluted earnings per share were $2.50 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did PAHC last report financial results?

The latest statements here come from Phibro Animal Health Corporation's 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.

Financials · PAHC

Phibro Animal Health Corporation (PAHC) financials

For the twelve months ended Sep 30, 2026, Phibro Animal Health Corporation reported $1.54B of revenue and $102.71M of net income.

Revenue, TTM: $1.54B
Revenue growth, YoY: +10.1%
Net income, TTM: $102.71M
Net income growth, YoY: +51.5%
Net margin: 6.7%
Free cash flow, TTM: $21.67M
EPS, diluted, TTM: $2.50
EPS growth, YoY: +49.7%
Cash: $75.55M
Total debt: $610.88M
P/E: 13.68
P/S: 0.91
Market cap: $1.41B

Annual revenue$1.52B

FY2017FY2026

Annual net income$99.72M

FY2017FY2026

Annual free cash flow$9.87M

FY2017FY2026

PAHC revenue and earnings growth

PAHC revenueQ1 2027$386.77M

Quarter YoY: +6.3%
QoQ: -2.5%
FY YoY: +17.1%
5Y CAGR: +12.7%
10Y CAGR: +7.3%

PAHC revenue was $386.77M in fiscal Q1 2027 (ended Sep 30, 2026), up 6.3% from a year earlier and down 2.5% from the prior quarter. For the full fiscal 2026 it was $1.52B, up 17.1% from fiscal 2025. Compound annual growth was +12.7% over 5 years and +7.3% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2026 is the highest of the 15 fiscal years on file.

PAHC net incomeQ1 2027$29.52M

Quarter YoY: +11.3%
QoQ: +36.0%
FY YoY: +106.6%
5Y CAGR: +12.9%
10Y CAGR: +1.9%

PAHC net income was $29.52M in fiscal Q1 2027 (ended Sep 30, 2026), up 11.3% from a year earlier and up 36.0% from the prior quarter. For the full fiscal 2026 it was $99.72M, up 106.6% from fiscal 2025. Compound annual growth was +12.9% over 5 years and +1.9% over 10 years. It rose in 4 of the last 10 fiscal years. Fiscal 2026 is the highest of the 15 fiscal years on file.

PAHC EPSQ1 2027$0.72

Quarter YoY: +10.8%
QoQ: +38.5%
FY YoY: +104.2%
5Y CAGR: +12.6%

PAHC diluted EPS was $0.72 in fiscal Q1 2027 (ended Sep 30, 2026), up 10.8% from a year earlier and up 38.5% from the prior quarter. For the full fiscal 2026 it was $2.43, up 104.2% from fiscal 2025. Compound annual growth was +12.6% over 5 years.

PAHC free cash flowQ1 2027$7.30M

QoQ: +39.7%
FY YoY: -76.4%
5Y CAGR: -12.3%
10Y CAGR: +27.5%

PAHC free cash flow was $7.30M in fiscal Q1 2027 (ended Sep 30, 2026), compared with -$4.50M a year earlier and up 39.7% from the prior quarter. For the full fiscal 2026 it was $9.87M, down 76.4% from fiscal 2025. Compound annual growth was -12.3% over 5 years and +27.5% over 10 years.

Export CSV

Income statement

Income statement
Line item	FY2026 Jun 30, 2026	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017
Revenue	$1.52B	$1.30B	$1.02B	$977.89M	$942.26M	$833.35M	$800.35M	$828.00M	$819.98M	$764.28M
Cost of revenue	$1.01B	$896.27M	$704.59M	$679.65M	$656.86M	$561.97M	$543.47M	$563.37M	$553.10M	$516.04M
Gross profit	$512.51M	$399.94M	$313.09M	$298.24M	$285.40M	$271.38M	$256.88M	$264.62M	$266.88M	$248.24M
Research and development	$24.55M	$23.73M	$29.19M	$24.39M	$20.83M	$17.76M	$13.74M	$12.09M	$10.00M	$9.44M
Selling, general and admin	$318.12M	$289.48M	$259.78M	$226.39M	$206.41M	$196.51M	$187.69M	$181.40M	$167.95M	$150.31M
Operating income	$194.40M	$110.47M	$53.31M	$71.85M	$78.99M	$74.87M	$69.19M	$83.23M	$98.93M	$97.93M
Interest expense	$46.42M	$37.22M	$23.01M	$18.68M	$12.69M	$13.72M	$14.61M	$13.68M	$13.60M	-
Pre-tax income	$137.35M	$67.99M	$10.92M	$54.07M	$72.33M	$66.47M	$55.51M	$71.50M	$88.07M	$80.54M
Income tax	$37.63M	$19.73M	$8.50M	$21.46M	$23.15M	$12.08M	$21.96M	$16.79M	$23.19M	$15.93M
Net income	$99.72M	$48.26M	$2.42M	$32.61M	$49.17M	$54.38M	$33.55M	$54.71M	$64.88M	$64.61M
EPS, basic	$2.46	$1.19	$0.06	$0.81	$1.21	$1.34	$0.83	$1.35	$1.61	$1.63
EPS, diluted	$2.43	$1.19	$0.06	$0.81	$1.21	$1.34	$0.83	$1.35	$1.61	$1.61
Diluted shares	41.0M	40.7M	40.5M	40.5M	40.5M	40.5M	40.5M	40,523	40,385	40,042

Balance sheet

Balance sheet
Line item	FY2026 Jun 30, 2026	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017
Cash and equivalents	$61.42M	$68.04M	$70.61M	$41.28M	$74.25M	$50.21M	$36.34M	$57.57M	$29.17M	$56.08M
Short-term investments	$20.57M	$9.00M	$44.00M	$40.00M	$17.00M	$43.00M	$55.00M	$24.00M	$50.00M	-
Receivables	$238.79M	$227.98M	$169.45M	$163.48M	$166.54M	$146.85M	$126.52M	$159.02M	$135.74M	$125.85M
Inventory	$534.88M	$444.43M	$265.91M	$277.57M	$259.16M	$216.31M	$196.66M	$198.32M	$178.17M	$161.23M
Current assets	$935.51M	$810.61M	$601.00M	$585.72M	$566.23M	$498.91M	$451.84M	$466.16M	$415.46M	$363.67M
Goodwill	$60.05M	$59.65M	$54.56M	$53.27M	$53.23M	$52.68M	$52.68M	$27.35M	$27.35M	$23.98M
Total assets	$1.50B	$1.36B	$982.18M	$971.40M	$931.70M	$841.33M	$784.10M	$726.67M	$671.68M	$623.40M
Current liabilities	$316.47M	$293.47M	$204.15M	$176.00M	$190.83M	$164.12M	$157.24M	$154.23M	$143.22M	$115.80M
Short-term debt	$25.02M	$16.25M	$29.80M	$22.30M	$15.00M	-	-	-	-	$6.25M
Long-term debt	$591.77M	$615.43M	$282.29M	$311.54M	$272.93M	$297.08M	$218.01M	$217.63M	$229.80M	$241.89M
Total debt	$616.79M	$631.68M	$312.08M	$333.84M	$287.93M	$297.08M	$218.01M	$217.63M	$229.80M	$248.14M
Total liabilities	$1.12B	$1.08B	$725.54M	$688.89M	$669.26M	$602.80M	$595.90M	$510.66M	$486.73M	$472.24M
Shareholders' equity	$385.48M	$285.68M	$256.64M	$282.51M	$262.44M	$238.53M	$188.20M	$216.01M	$184.95M	$151.16M

Cash flow

Cash flow
Line item	FY2026 Jun 30, 2026	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017
Operating cash flow	$68.95M	$80.12M	$87.59M	$13.31M	$31.65M	$48.31M	$59.35M	$47.17M	$70.01M	$98.39M
Capital expenditures	$59.09M	$38.29M	$41.24M	$51.79M	$37.04M	$29.32M	$34.05M	$29.89M	$18.55M	$20.88M
Free cash flow	$9.87M	$41.83M	$46.36M	-$38.48M	-$5.39M	$18.99M	$25.30M	$17.28M	$51.46M	$77.50M
Investing cash flow	-$71.45M	-$288.69M	-$48.19M	-$74.02M	-$22.58M	-$18.58M	-$120.39M	-$14.13M	-$84.61M	-$21.94M
Financing cash flow	-$6.56M	$207.13M	-$6.77M	$26.99M	$16.34M	-$17.00M	$40.94M	-$4.11M	-$11.78M	-$53.74M
Dividends paid	$19.46M	$19.45M	$19.44M	$19.44M	$19.44M	$19.43M	$19.42M	$18.59M	$16.07M	$15.83M
Stock-based compensation	$1.60M	$717.0K	$475.0K	-	-	$1.13M	$2.26M	$2.26M	$334.0K	$0
Depreciation and amortization	$51.51M	$45.60M	$36.18M	$34.01M	$32.70M	$31.89M	$32.34M	$27.56M	$26.94M	$26.00M

Key ratios

Key ratios
Line item	FY2026 Jun 30, 2026	FY2025 Jun 30, 2025	FY2024 Jun 30, 2024	FY2023 Jun 30, 2023	FY2022 Jun 30, 2022	FY2021 Jun 30, 2021	FY2020 Jun 30, 2020	FY2019 Jun 30, 2019	FY2018 Jun 30, 2018	FY2017 Jun 30, 2017
Revenue growth, YoY	17.1%	27.4%	4.1%	3.8%	13.1%	4.1%	-3.3%	1.0%	7.3%	1.7%
Net income growth, YoY	106.6%	1897.7%	-92.6%	-33.7%	-9.6%	62.1%	-38.7%	-15.7%	0.4%	-21.9%
EPS growth, YoY	104.2%	1883.3%	-92.6%	-33.1%	-9.7%	61.4%	-	-16.1%	0.0%	-22.2%
Gross margin	33.8%	30.9%	30.8%	30.5%	30.3%	32.6%	32.1%	32.0%	32.5%	32.5%
Operating margin	12.8%	8.5%	5.2%	7.3%	8.4%	9.0%	8.6%	10.1%	12.1%	12.8%
Net margin	6.6%	3.7%	0.2%	3.3%	5.2%	6.5%	4.2%	6.6%	7.9%	8.5%
Free cash flow margin	0.6%	3.2%	4.6%	-3.9%	-0.6%	2.3%	3.2%	2.1%	6.3%	10.1%
Return on equity	25.9%	16.9%	0.9%	11.5%	18.7%	22.8%	17.8%	25.3%	35.1%	42.7%
Return on assets	6.6%	3.5%	0.2%	3.4%	5.3%	6.5%	4.3%	7.5%	9.7%	10.4%
Current ratio	2.96	2.76	2.94	3.33	2.97	3.04	2.87	3.02	2.90	3.14
Debt to equity	1.60	2.21	1.22	1.18	1.10	1.25	1.16	1.01	1.24	1.64

Income statement

Income statement
Line item	Q1 2027 Sep 30, 2026	Q4 2026* Jun 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023
Revenue	$386.77M	$396.75M	$383.54M	$373.91M	$363.89M	$378.70M	$347.82M	$309.26M	$260.43M	$273.16M	$263.22M	$249.94M
Cost of revenue	$258.24M	$262.35M	$257.87M	$241.25M	$244.11M	$268.69M	$243.26M	$207.39M	$176.94M	$186.01M	$183.62M	$171.33M
Gross profit	$128.54M	$134.40M	$125.67M	$132.66M	$119.78M	$110.01M	$104.57M	$101.87M	$83.50M	$87.15M	$79.60M	$78.62M
Selling, general and admin	$78.90M	$86.24M	$81.02M	$82.33M	$68.52M	$76.29M	$71.05M	$76.34M	$65.80M	$68.73M	$59.68M	$62.91M
Operating income	$49.64M	$48.16M	$44.65M	$50.33M	$51.26M	$33.72M	$33.52M	$25.53M	$17.70M	$18.42M	$19.92M	$15.70M
Interest expense	$12.25M	$10.71M	$10.68M	$12.48M	$12.54M	$9.03M	$9.65M	$9.78M	$8.77M	$6.00M	$5.64M	$5.72M
Pre-tax income	$38.78M	$32.34M	$32.31M	$36.42M	$36.27M	$23.85M	$29.69M	$4.84M	$9.62M	$6.41M	$12.92M	$3.56M
Income tax	$9.26M	$10.63M	$8.29M	$8.97M	$9.74M	$6.62M	$8.81M	$1.65M	$2.65M	$5.66M	$4.52M	$2.29M
Net income	$29.52M	$21.71M	$24.02M	$27.46M	$26.53M	$17.22M	$20.88M	$3.19M	$6.97M	$752.0K	$8.40M	$1.27M
EPS, basic	$0.73	$0.54	$0.59	$0.68	$0.65	$0.42	$0.52	$0.08	$0.17	$0.02	$0.21	$0.03
EPS, diluted	$0.72	$0.52	$0.59	$0.67	$0.65	$0.43	$0.51	$0.08	$0.17	$0.02	$0.21	$0.03
Diluted shares	41.0M	-	41.0M	41.0M	40.9M	-	40.7M	40.7M	40.6M	-	40.5M	40.5M

Balance sheet

Balance sheet
Line item	Q1 2027 Sep 30, 2026	Q4 2026* Jun 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023
Cash and equivalents	$75.55M	$61.42M	$54.93M	$55.49M	$72.77M	$68.04M	$60.35M	$67.07M	$51.84M	$70.61M	$50.23M	$32.97M
Short-term investments	$7.58M	$20.57M	$22.52M	$19.02M	$12.50M	$9.00M	$10.00M	$0	$38.00M	$44.00M	$48.52M	$59.52M
Receivables	$221.71M	$238.79M	$221.55M	$215.87M	$217.90M	$227.98M	$197.52M	$191.79M	$160.78M	$169.45M	$161.09M	$150.63M
Inventory	$567.14M	$534.88M	$539.70M	$517.35M	$471.77M	$444.43M	$448.39M	$427.22M	$272.56M	$265.91M	$282.29M	$286.68M
Current assets	$945.17M	$935.51M	$894.07M	$862.18M	$835.80M	$810.61M	$776.02M	$746.15M	$570.77M	$601.00M	$597.18M	$586.59M
Goodwill	$60.03M	$60.05M	$59.89M	$59.81M	$59.71M	$59.65M	$54.57M	$54.55M	$54.59M	$54.56M	$54.64M	$54.68M
Total assets	$1.51B	$1.50B	$1.45B	$1.41B	$1.39B	$1.36B	$1.32B	$1.29B	$966.29M	$982.18M	$979.03M	$972.71M
Current liabilities	$295.79M	$316.47M	$281.87M	$282.37M	$270.14M	$293.47M	$266.48M	$233.25M	$176.89M	$204.15M	$189.07M	$187.74M
Short-term debt	$25.02M	$25.02M	$22.83M	$20.64M	$18.44M	$16.25M	$16.25M	$16.25M	$7.50M	$29.80M	$29.81M	$26.05M
Long-term debt	$585.85M	$591.77M	$597.68M	$603.60M	$609.52M	$615.43M	$619.16M	$622.88M	$287.67M	$282.29M	$291.01M	$297.85M
Total debt	$610.88M	$616.79M	$620.52M	$624.24M	$627.96M	$631.68M	$635.41M	$639.13M	$295.17M	$312.08M	$320.82M	$323.90M
Total liabilities	$1.10B	$1.12B	$1.08B	$1.07B	$1.07B	$1.08B	$1.05B	$1.04B	$707.76M	$725.54M	$708.94M	$701.90M
Shareholders' equity	$417.67M	$385.48M	$361.83M	$332.36M	$311.68M	$285.68M	$265.99M	$246.80M	$258.53M	$256.64M	$270.09M	$270.80M

Cash flow

Cash flow
Line item	Q1 2027 Sep 30, 2026	Q4 2026* Jun 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023
Operating cash flow	$26.08M	$24.09M	$16.21M	$19.35M	$9.30M	$21.27M	$43.15M	$3.08M	$12.62M	$28.43M	$11.41M	$31.56M
Capital expenditures	$18.78M	$18.87M	$15.32M	$11.10M	$13.81M	$13.14M	$7.75M	$7.82M	$9.58M	$13.07M	$9.73M	$10.96M
Free cash flow	$7.30M	$5.22M	$890.0K	$8.26M	-$4.50M	$8.13M	$35.41M	-$4.75M	$3.04M	$15.36M	$1.68M	$20.60M
Investing cash flow	-$5.95M	-$16.45M	-$16.81M	-$17.18M	-$21.01M	-$7.03M	-$18.25M	-$260.47M	-$2.93M	-$9.11M	$1.13M	-$24.86M
Financing cash flow	-$5.63M	-$1.61M	-$2.30M	-$18.98M	$16.34M	-$7.77M	-$32.22M	$276.32M	-$29.20M	$1.79M	$4.85M	-$14.71M
Dividends paid	$4.87M	$4.87M	$4.87M	$4.86M	$4.86M	$4.86M	$4.87M	$4.86M	$4.86M	$4.86M	$4.86M	$4.86M
Stock-based compensation	$804.0K	$413.0K	$411.0K	$434.0K	$339.0K	$179.0K	$179.0K	$180.0K	$179.0K	$179.0K	$135.0K	$80.0K
Depreciation and amortization	$13.58M	$13.35M	$12.45M	$12.89M	$12.83M	$12.41M	$12.62M	$11.57M	$9.00M	$9.20M	$9.20M	$8.91M

Key ratios

Key ratios
Line item	Q1 2027 Sep 30, 2026	Q4 2026* Jun 30, 2026	Q3 2026 Mar 31, 2026	Q2 2026 Dec 31, 2025	Q1 2026 Sep 30, 2025	Q4 2025* Jun 30, 2025	Q3 2025 Mar 31, 2025	Q2 2025 Dec 31, 2024	Q1 2025 Sep 30, 2024	Q4 2024* Jun 30, 2024	Q3 2024 Mar 31, 2024	Q2 2024 Dec 31, 2023
Revenue growth, YoY	6.3%	4.8%	10.3%	20.9%	39.7%	38.6%	32.1%	23.7%	12.6%	7.1%	7.1%	2.2%
Net income growth, YoY	11.3%	26.0%	15.1%	762.1%	280.3%	2190.4%	148.4%	150.0%	-	-93.5%	-16.3%	-82.3%
EPS growth, YoY	10.8%	20.9%	15.7%	737.5%	282.4%	2050.0%	142.9%	166.7%	-	-92.9%	-16.0%	-83.3%
Gross margin	33.2%	33.9%	32.8%	35.5%	32.9%	29.0%	30.1%	32.9%	32.1%	31.9%	30.2%	31.5%
Operating margin	12.8%	12.1%	11.6%	13.5%	14.1%	8.9%	9.6%	8.3%	6.8%	6.7%	7.6%	6.3%
Net margin	7.6%	5.5%	6.3%	7.3%	7.3%	4.5%	6.0%	1.0%	2.7%	0.3%	3.2%	0.5%
Free cash flow margin	1.9%	1.3%	0.2%	2.2%	-1.2%	2.1%	10.2%	-1.5%	1.2%	5.6%	0.6%	8.2%
Current ratio	3.20	2.96	3.17	3.05	3.09	2.76	2.91	3.20	3.23	2.94	3.16	3.12
Debt to equity	1.46	1.60	1.71	1.88	2.01	2.21	2.39	2.59	1.14	1.22	1.19	1.20

Source: XBRL data Phibro Animal Health Corporation files with the SEC, latest filing dated Nov 4, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

PAHC peers

Company	Revenue	Growth	Net income	Net margin	Market cap
PAHC	$1.54B	+10.1%	$102.71M	6.7%	$1.41B
LLYEli Lilly and Company	$86.46B	+45.5%	$27.58B	31.9%	$1.33T
JNJJohnson & Johnson	$99.33B	+7.8%	$16.09B	16.2%	$679.13B
ABBVAbbVie Inc.	$66.01B	+10.7%	$10.34B	15.7%	$518.44B
MRKMerck & Company Inc.	$67.38B	+4.9%	$2.45B	3.6%	$366.73B
NVSNovartis AG	$54.53B	+8.4%	$13.98B	25.6%	$312.35B
AZNAstraZeneca PLC	$58.74B	+8.6%	$10.22B	17.4%	$293.69B
ABTAbbott Laboratories	$48.23B	+10.0%	$4.70B	9.7%	$191.40B
NVONovo Nordisk A/S	DKK 309.06B	+6.4%	DKK 102.43B	33.1%	$183.23B

PAHC FAQ

9 questions

What is PAHC revenue?
Phibro Animal Health Corporation (PAHC) reported $1.54B of revenue for the twelve months ended Sep 30, 2026. That is up 10.1% from the year before. Revenue for fiscal 2026 was $1.52B.
Is PAHC profitable?
Yes. Phibro Animal Health Corporation earned $102.71M in net income for the twelve months ended Sep 30, 2026, a net margin of 6.7%.
How much cash and debt does PAHC have?
Phibro Animal Health Corporation reported $75.55M in cash and cash equivalents and $610.88M of debt on its most recent balance sheet in SEC filings.
How fast is PAHC revenue growing?
Phibro Animal Health Corporation's revenue changed +17.1% in fiscal 2026, to $1.52B. Its compound annual growth rate was +12.7% over 5 years and +7.3% over 10 years.
What is PAHC gross margin?
Phibro Animal Health Corporation's gross profit was $521.27M on $1.54B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 33.8%.
What is PAHC free cash flow?
Phibro Animal Health Corporation generated $21.67M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $85.73M less capital expenditures.
What is PAHC earnings per share?
Diluted earnings per share were $2.50 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did PAHC last report financial results?
The latest statements here come from Phibro Animal Health Corporation's 10-Q filed on Nov 4, 2026, covering the period ended Sep 30, 2026.
Where does this PAHC financial data come from?
Quantisnow builds these statements from the structured XBRL data Phibro Animal Health Corporation files with the SEC. It is provided for information only and is not investment advice.